Home > Healthcare > Medical Devices > Diagnostic Devices > Mammography Systems Market
Mammography systems market share from the full field digital mammography product segment will exhibit over 7% CAGR through 2032, considering its ability to provide better image resolution and early cancer detection compared to other machines. Digital mammography permits more accurate and rapid needle placement, thereby speeding the biopsy procedure and lowering discomfort. Moreover, its superior contrast resolution and the ability to manipulate images can ensure more accurate breast cancer detection. These positive features, along with the availability of favorable healthcare reimbursement policies, will accelerate product consumption over the forecast period.
Based on the end-use, the mammography systems market size from the ambulatory surgical centers segment is projected to reach more than USD 1.5 billion by 2032. The increasing awareness about the role of ASCs in preventive cancer care and early cancer detection is a factor bolstering the use of mammography equipment. These centers are equipped with advanced tech-powered cancer detection devices for precise diagnostic procedures. Furthermore, good regulatory practices and shorter procedural time are also expected to also fuel the demand for mammography systems in ASCs for cancer diagnosis.
From a regional perspective, the North America mammography systems market will be valued at over USD 2 billion by 2032, as a result of the increased incidence of breast cancer. The strong presence of market players involved in the R&D of technology-enabled cancer detection systems is another factor driving market expansion. The number of elderly people susceptible to cancer due to hormonal fluctuation has also surged. In addition, the development of sophisticated healthcare infrastructure will add impetus to the North American market growth.